Navigation Links
Cequent in Medical Technology

Cequent tkRNAi Technology to be Presented at the Centennial Meeting of the American Association for Cancer Research

...racts CAMBRIDGE, Mass., April 15 /PRNewswire/ -- cequent Pharmaceuticals, a pioneer in the development of n...cinoma, ovarian cancer, and others. About cequent Pharmaceuticals, Inc. ( www.cequentpharma.com ) An early-stage biopharmaceutical company, cequent is pioneering the development of novel therapeutic...

Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference

... CAMBRIDGE, Mass., Jan. 6 /PRNewswire/ -- cequent Pharmaceuticals, a pioneer in the development of n...ncer, and there is no medical treatment available. cequent will present its findings, the first-ever proof of... implicated in the progression of a disease," said cequent President and CEO, Peter Parker. "We have shown pr...

Cequent Pharmaceuticals' Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008

... CAMBRIDGE, Mass., April 30 /PRNewswire/ -- cequent Pharmaceuticals, a pioneer in the development of n...a non-human primate model -- an important step for cequent in the development of tkRNAi-based drugs for human...eline are based on this tkRNAi technology. About cequent Pharmaceuticals, Inc. An early-stage biopharmace...

Cequent Pharmaceuticals Founder to Present tkRNAi Technology at the American Association of Cancer Research Annual Meeting in Los Angeles

...s pipeline of clinical drug candidates. About cequent Pharmaceuticals, Inc. An early-stage biopharmaceutical company, cequent is pioneering the development of novel therapeutic...ly held company based in Cambridge, Massachusetts, cequent was established in 2006 with seed funding from Amp...
Cequent in Biological Technology

Two Luminaries Join Cequent Scientific Advisory Board: Judy Lieberman, M.D. Ph.D., and Patrice Courvalin, M.D.

Dr. Lieberman, of Harvard Medical School, is a prominent expert on RNAi delivery for therapeutic uses; Dr. Courvalin, of the Institut Pasteur, Paris, France, is foremost authority on bacterial genetic transfer CAMBRIDGE, Mass., Oct. 6 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in ...

Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals' Board of Directors

CAMBRIDGE, Mass., May 5 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Michael D. Taylor, Ph.D., has joined the company's board of directors. Dr. Taylor is president and...

TriMas Corporation's Cequent Group Acquires Chem-Chrome, Inc.

TriMas Corporation, a growth company of diversified businesses, announced today that its Cequent Transportation Accessories Group has acquired Chem-Chrome, Inc., a provider of zinc plating services. Chem-Chrome is headquartered in Schofield, Wis. and has been a longtime processor for Cequent's Trai...

Cequent Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases

... CAMBRIDGE, Mass., June 2 /PRNewswire/ -- cequent Pharmaceuticals, a pioneer in the development of n...s a scientist in 2007. Today, he leads the team of cequent researchers developing drug candidates using Ceque... our rapid progress over the past 18 months," said cequent President and CEO, Peter Parker. "We started with ...

Cequent Names Ted Hibben Chief Business Officer

... CAMBRIDGE, Mass., Jan. 12 /PRNewswire/ -- cequent Pharmaceuticals, a pioneer in the development of n...any as chief business officer. Mr. Hibben comes to cequent from Coley Pharmaceutical Group, where he was most...velopment against multiple diseases. Ted brings to cequent a wealth of experience orchestrating a full range ...

Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo

... CAMBRIDGE, Mass., Sept. 15 /PRNewswire/ -- cequent Pharmaceuticals, a pioneer in the development of n... target the individual forms of the disease," said cequent President and CEO, Peter Parker. "When we started ...l further validate in in vivo animal trials before cequent selects the single target to be the subject of the...
Other Tags
(Date:9/30/2014)... 2014 From October 12-15, MMS, ... the 2014 SHSMD Connections Annual Conference in San Diego, ... & Market Development (SHSMD) is proud to host the ... and communications, and strategic planning professionals in San Diego ... , The conference is a four-day event designed ...
(Date:9/30/2014)... IN (PRWEB) September 30, 2014 ... Ron Receveur encourages all persons who have received dental ... in a recent blog post. , The post, which ... with dental implants that if they don’t brush and ... same way people lose their natural teeth: the bone ...
(Date:9/30/2014)... “Biology and botany are having an ... it’s about naming rights.” , In Homeostasis: ... the Bryan William Brickner Blog, the focus is ... Health (PubMed). The post highlights five cannabinoid system ... aging with THC, the wake-inducing effects of CBD, ...
(Date:9/30/2014)... September 30, 2014 Named a ... East Longmeadow facility has officially announced that they ... that combines advanced medical technology with supportive, ... one of the only non-hospital options available in ... The primary focus of this Ventilator Program ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 American Medical ... a collaborative agreement to raise awareness about Alzheimer’s disease ... IDs for people with these brain disorders. , American ... generated by AFA to the foundation to support its ... their families. The ID bracelets and necklaces can be ...
Breaking Medicine News(10 mins):Health News:MMS, Inc. (Medical Marketing Service) to Attend the 2014 SHSMD Connections Annual Conference in October 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 3Health News:Homeostasis: Publius’ Sleep Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2Health News:Wingate Healthcare Announces New Ventilator Care Program at East Longmeadow Facility 2Health News:Wingate Healthcare Announces New Ventilator Care Program at East Longmeadow Facility 3Health News:American Medical ID and Alzheimer’s Foundation of America Team up to Increase Awareness about Alzheimer’s Disease and Related Dementias 2Health News:American Medical ID and Alzheimer’s Foundation of America Team up to Increase Awareness about Alzheimer’s Disease and Related Dementias 3
(Date:9/28/2014)... findings by scientists at the University of California, Santa ... elements within the genomes of primates drove the evolution ... genes in every cell of our bodies. , ... as "retrotransposons" (a.k.a. "jumping genes") and the genes that ... researchers have, for the first time, identified genes in ...
(Date:9/27/2014)... expression levels of an enzyme involved in DNA synthesis ... certain treatments, a Korean study has shown at the ... phase II study, researchers showed that patients whose lung ... synthase experienced a greater benefit from treatment with the ... expressed high levels. , "Thymidylate synthase is one ...
(Date:9/27/2014)... and body mass in patients with advanced lung cancer ... phase III data presented at the ESMO 2014 Congress ... are among the most troubling and distressing symptoms of ... the study,s principal investigator, Dr Jennifer Temel from the ... Symptoms of the wasting syndrome can include a loss ...
Breaking Biology News(10 mins):Human genome was shaped by an evolutionary arms race with itself 2Human genome was shaped by an evolutionary arms race with itself 3Human genome was shaped by an evolutionary arms race with itself 4Customising chemotherapy in Lu Ca: New Ph II data reported in 2 LB studies 2Customising chemotherapy in Lu Ca: New Ph II data reported in 2 LB studies 3Customising chemotherapy in Lu Ca: New Ph II data reported in 2 LB studies 4Anamorelin improve appetite and body mass in patients with cancer anorexia-cachexia 2Anamorelin improve appetite and body mass in patients with cancer anorexia-cachexia 3Anamorelin improve appetite and body mass in patients with cancer anorexia-cachexia 4
Other Contents